Table 1.
Predictor | Method | Studies, N | Age-associated outcome | References |
---|---|---|---|---|
DNAmAge | DNA methylation | 100 + | Mortality, frailty, cognition, physical function, self-rated health, AD, PD, cancer | Horvath (2013), Hannum et al. (2013) |
Telomere length | qPCR (T/S-ratio), Sothern blot (bp) | 1000 + | Mortality, cancer, CVD, AD, physical function, cognition | Blackburn et al. (2006) |
Transcriptomic age | Gene expression | 2 | IL-6, urea, albumin, muscle strength, blood pressure, lipids, glucose, BMI, smoking | Holly et al. (2013), Peters et al. (2015) |
Glycan age | Glycans, proteomics | 1 | Fibrinogen, HbA1c, BMI, triglycerides, uric acid | Kristic et al. (2014) |
Protein-derived age | Proteomics | 1 | Low birth weight, Framingham risk score | Menni et al. (2015) |
C-glyTrp | Metabolomics | 1 | Lung function, hip bone mineral density | Menni et al. (2013) |
Metabolic age score | Metabolomics | 1 | Mortality, kidney function, HbA1c, hyperglyceridemia | Hertel et al. (2016) |
Composite biomarker | 10 biomarkers combined | 3 | Mortality, IQ, physical function | Levine (2013), Belsky et al. (2015) |
Composite biomarker | 19 biomarkers in a clustering approach | 1 | Mortality, cancer, CVD, T2D, physical function, cognition | Sebastiani et al. (2017) |
AD, Alzheimer's Disease; PD, Parkinson's Disease; CVD, cardiovascular disease; T2D, type 2 diabetes; IL-6, interleukine 6; BMI, body mass index.